Signadori Bio
PrivateLast Round
Seed
May 6, 2026
Total Funding Raised
$13M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Signadori Bio operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in May 2026.
Signadori Bio is a biopharmaceutical company developing a next-generation, off-the-shelf, in vivo engineered, monocyte immunotherapy platform to treat solid tumours.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signadori Bio Comparables
Compare Signadori Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 80% | |
| Liberate Bio | 76% | |
| CREATE Medicines | 74% |
For institutional investors. Book with your work email.
Signadori Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Signadori Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiho Ventures | Seed |
| Sofinnova Partners | Seed |
| Invivo Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2026
Grew 75% QoQ from 4 to 7 employees.
- May 6, 2026
$13M round with Taiho Ventures and Invivo Partners.
For institutional investors. Book with your work email.
Signadori Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Signadori Bio's valuation, stock price, and market status.
Is Signadori Bio a public or private company?
Signadori Bio is a private company.
What is the current stock price of Signadori Bio?
Signadori Bio is a private company, so its shares have no public market price. Caplight tracks Signadori Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Signadori Bio worth (valuation)?
Valuation information for Signadori Bio is not publicly available.
Can I buy Signadori Bio stock?
Signadori Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Signadori Bio's last funding round?
Signadori Bio's most recent funding round was Seed on May 6, 2026.
Who are the main investors in Signadori Bio?
Key investors in Signadori Bio include Taiho Ventures, Sofinnova Partners, Invivo Partners.
Will Signadori Bio IPO soon?
No public IPO plans have been announced for Signadori Bio.
How can I track Signadori Bio secondary market activity?
Caplight tracks bids, offers, and trades in Signadori Bio's shares on secondary markets.